Swiss Pharma Giant Roche Suspends German Capital Commitments Amid Dispute Over Drug Discounts
Roche halts German investments as chief Daniel Steiners warns Berlin that statutory drug rebates shatter trust in the market.
This is a short summary. The full story is published by Benzinga.
Read full story at Benzinga


